All News

Find press releases issued in the past two years issued by Johnson & Johnson corporate headquarters and our operating companies.

< Prev | | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | .... 39 Next >

FDA Grants Accelerated Approval for SIRTURO™ (bedaquiline) as Part of Combination Therapy to Treat Adults with Pulmonary Multi-Drug Resistant Tuberculosis

December 31, 2012

New Category I CPT Codes and Payment Rates for Circulating Tumor Cell Testing Effective January 1

December 27, 2012

Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter/Full-Year 2012 Financial Results and Medical Devices and Diagnostics Review

December 21, 2012

Max Reinhardt Named Worldwide President Of Depuy Synthes Spine

December 13, 2012

The New England Journal of Medicine Publishes Efficacy Data for ZYTIGA® Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer in Patients Who Have Not Received Chemotherapy

December 12, 2012

CellSearch® 'Liquid Biopsy' Approved for Breast Cancer Patients in China

December 12, 2012

< Prev | | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | .... 39 Next >

Employees

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.